((Professor Sherif El-Messiri patents a new drug that eliminates breast cancer forever and erases it from existence))

How many women in the world suffer and scream every second from the aches and pains of breast cancer, and how many mothers, sisters and wives have lost and died due to breast cancer, that savage monster that snatches the souls of the people we love most, our mothers, sisters and wives.

Every 50 seconds in some part of the world, a person dies from breast cancer, meaning more than 1,700 women and men every day.

Cancer is the second leading cause of death in the world. From 2014 to 2018, it claimed the lives of 810 million people, with approximately one out of every six deaths worldwide attributed to it.

Low- and middle-income countries account for approximately 70% of deaths resulting from cancer, according to United Nations estimates.

Cancer is one of the most painful and torturous diseases, and breast cancer is at the forefront of the types of cancer that affect women in the developed and developing world alike. High rates of the incidence of this cancer are noted in the developing world. Although preventive strategies can contribute to reducing some of the risks of breast cancer, These strategies do not eliminate most cases of this cancer that appear in poor countries, where this disease is not diagnosed except in the late stages.

Accordingly, early detection in order to improve breast cancer outcomes and improve the recovery rates of its patients remains the cornerstone of combating this disease.

Early detection strategies recommended for low- and middle-income countries are attention to the first signs and symptoms and clinical breast examination in designated display areas.

The World Health Organization seeks to strengthen the fight against breast cancer within the framework of national cancer control programs and integrated programs to prevent and control noncommunicable diseases.

(WHO report on the global burden of disease 2018).

Early diagnosis is important in all situations, and with regard to most types of cancer, and in the absence of early diagnosis, patients are not subject to diagnosis except in the late stages, when curative treatment may not be an option available to them after that.

In my time with the pain of many sisters and mothers afflicted with breast cancer, I worked day and night for years conducting research and experiments to fight this dreaded disease, praying to God Almighty to inspire me to do what is right and to send down the cure and cure just as He sent down the disease, until the efforts were crowned with success.

Thanks to God Almighty, I have found an effective and successful drug that completely eradicates breast cancer, consisting of a complex complex of proteins, including the components of ricin poison extracted from the seeds of the castor plant and some components of the poison Abrin extracted from the red seeds of the pea plant (Ain al-Afrit) in combination with the enzyme melittin. Mellitin extracted from bee venom.

The idea of the new drug's work is that (ricin and arpine poison), which is one of the most deadly types of poisons on the face of the earth, and there is no antidote or treatment for it, as an amount the size of a pinhead is capable of killing 5,000 adults within hours.

The compound extracted from ricin and arpine inhibits the synthesis of proteins in cells

("ribosome-inactivating proteins"(RIPs)

These are called Type 1 RIPs

They cannot enter from the cell surface to reach ribosomes unless they combine with a disulfide bridge to form (Type 2 RIPs).

It is an enzyme also called when the A chain is attached to it with a disulfide bond and the RTB molecule with ricin combines with glucoproteins and glucolipids on the cell surface that ends with galactose.

About 106-108 ricin molecules can combine with each cell, and just one ricin molecule that enters the cell stops the activity of 1,500 ribosomes per minute, completely killing and eliminating the cancer cell.

The enzyme melittin, which is extracted from bee venom, is an anti-inflammatory substance 100 times as powerful as cortisone. It also contains Dolapin, which is a pain reliever 20 times as powerful as morphine and is also an antipyretic substance 5 times as powerful as aspirin, by providing relief to the patient and stopping the pain completely.

The drug was tested in a laboratory according to the controls of scientific, clinical and experimental research, and the results were successful. Then it was tried and applied clinically on a sample of 580 cases in the United States of America and 40 cases in the Arab Republic of Egypt. The results came with a success rate of 98%, and 11 cases failed to be treated because they entered the late stages of the disease. The conditions for the success of the drug are when treating in cases of early detection of the disease.

The patent was registered with the United States Patent and Trademark Office